OMEROS CORP
OMEROS CORP
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash And Cash Equivalents At Carrying Value | 2 | 2 | 10 | 2 | 2 | 4 | 3 | 2 | 2 | 2 | 7 | 31 | |||||
Short Term Investments | 130 | 133 | 162 | 34 | 27 | 48 | 87 | 122 | 157 | 229 | 165 | 280 | |||||
Receivables Net Current | 21 | 12 | 11 | 7 | 6 | 7 | 8 | 6 | 8 | 8 | 8 | 7 | |||||
Inventory Net | 1 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Assets Current | |||||||||||||||||
Assets Current | 185 | 180 | 216 | 72 | 70 | 96 | 134 | 165 | 203 | 281 | 218 | 351 | |||||
Prepaid Expense And Other Assets Current | 6 | 7 | 8 | 4 | 6 | 7 | 7 | 6 | 6 | 13 | 9 | 5 | |||||
Operating Lease Right Of Use Asset | 8 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 19 | |||||
Property Plant And Equipment Net | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | |||||
Restricted Cash And Cash Equivalents Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Assets | 287 | 286 | 326 | 186 | 201 | 235 | 277 | 313 | 356 | 437 | 378 | 493 | |||||
Accounts Payable Current | 6 | 5 | 5 | 12 | 9 | 4 | 6 | 8 | 7 | 6 | 8 | 6 | |||||
Accrued Liabilities Current | 29 | 28 | 29 | 26 | 26 | 25 | 26 | 23 | 28 | 28 | 32 | 35 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 95 | 59 | 78 | 81 | 86 | 83 | 80 | 56 | 59 | 59 | 53 | 147 | |||||
Senior Notes Current | 0 | 0 | 17 | 17 | 17 | 27 | 0 | - | - | - | 0 | 95 | |||||
Loans Payable Current | - | - | 0 | 0 | 0 | 0 | 21 | - | - | - | - | - | |||||
Shares Subject To Mandatory Redemption Settlement … | - | - | - | - | 8 | - | - | - | - | - | - | - | |||||
Senior Long Term Notes | 42 | 53 | 51 | 72 | 63 | 70 | 97 | 97 | 97 | 213 | 213 | 222 | |||||
Long Term Loans Payable | - | - | 0 | 87 | 87 | 89 | 70 | 92 | 95 | - | 0 | - | |||||
Derivative Liabilities Noncurrent | 55 | 84 | - | - | - | - | - | - | - | - | - | - | |||||
Other Accrued Liabilities Noncurrent | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 3 | 2 | 2 | 2 | 0 | |||||
Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Additional Paid In Capital Common Stock | - | - | - | - | - | - | - | 724 | 722 | 719 | 728 | 730 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | -51 | -63 | -121 | -220 | -229 | -214 | -183 | -154 | -125 | -71 | -25 | -14 | |||||
Additional Paid In Capital | 792 | 794 | 792 | 779 | 740 | 730 | 727 | - | - | - | 728 | - | |||||
Retained Earnings Accumulated Deficit | -844 | -858 | -914 | -1,000 | -969 | -944 | -910 | -879 | -847 | -791 | -754 | -744 | |||||
Liabilities And Stockholders Equity | 287 | 286 | 326 | 186 | 201 | 235 | 277 | 313 | 356 | 437 | 378 | 493 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | |||||
Common Stock Shares Issued | 72 | 72 | 72 | 70 | 60 | 58 | 58 | 58 | 58 | 58 | 61 | 63 | |||||
Shares Outstanding | 72 | 72 | 72 | 70 | 60 | 58 | 58 | 58 | 58 | 58 | 61 | 63 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -31.92% | -35.47% | -17.66% | - | - | - | - | - | - | - | - | - |
| 2025 | -4.56% | -18.99% | -8.61% | 1.21% | 11.17% | 77.91% | 72.77% | 160.83% | 86.15% | 28.12% | 8.52% | -2.65% |
| 2024 | -7.43% | -7.19% | 16.79% | 1.45% | -5.54% | 0.96% | 177.09% | 167.54% | 105.73% | -11.07% | -61.56% | -60.95% |
| 2023 | - | - | - | - | - | - | 76.98% | 159.52% | 161.11% | -1.25% | 5.02% | 24.45% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.95 | 3.03 | 2.76 | 0.89 | 0.81 | 1.16 | 1.69 | 2.96 | 3.41 | 4.76 | 4.09 | 2.39 | |||||
| Quick Ratio | 1.88 | 2.91 | 2.67 | 0.84 | 0.74 | 1.07 | 1.60 | 2.85 | 3.31 | 4.53 | 3.93 | 2.35 | |||||
| Working Capital | 90.28M | 120.91M | 137.61M | -8.95M | -15.86M | 12.96M | 54.59M | 109.30M | 143.46M | 221.90M | 164.58M | 204.16M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.85 | -0.94 | -0.64 | -0.37 | -0.37 | -0.39 | -0.44 | -0.36 | -0.48 | -0.83 | -2.13 | -10.55 | |||||
| Interest Coverage TTM | -2.05 | -3.76 | -4.77 | -6.29 | -12.49 | -8.10 | -6.77 | -6.07 | -5.74 | -5.39 | -5.33 | -5.20 | |||||
| Debt Ratio | 0.33 | 0.21 | 0.24 | 0.43 | 0.43 | 0.35 | 0.29 | 0.18 | 0.17 | 0.13 | 0.14 | 0.30 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.16 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Days Sales Outstanding TTM | 130.99 | 352.49 | - | - | - | - | - | - | - | - | - | - | |||||
| Receivables Turnover TTM | 2.79 | 1.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 1.39 | 0.96 | - | - | -2.09 | -2.64 | - | - | - | - | - | - | |||||
| Free Cash Flow Per Share TTM | -0.95 | -1.32 | -1.83 | -1.59 | -2.03 | -2.46 | -2.56 | -2.67 | -2.68 | -2.42 | 1.18 | 1.33 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | -189.53% | -1,063.86% | - | - | - | - | - | - | - | - | - | - | |||||
| Net Profit Margin TTM | 324.88% | 871.02% | - | - | - | - | - | - | - | - | - | - | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | -201.92% | -156.29% | -97.86% | -9.94% | -12.55% | 26.21% | 33.11% | -773.03% | -447.66% | -359.58% | -348.46% | -89.97% | |||||
| EPS Growth (1Y) | -182.78% | -145.44% | -98.04% | -21.24% | -13.50% | 27.83% | 43.56% | -830.04% | -477.01% | -377.37% | -348.45% | -89.99% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 5.50 | 8.81 | -325.70 | -2.24 | -1.44 | -3.12 | -3.67 | -1.71 | -1.68 | -1.67 | -1.74 | 9.18 | |||||
| P/B TTM | -13.36 | -11.99 | -9.00 | -1.23 | -0.77 | -2.23 | -3.15 | -1.49 | -1.89 | -2.84 | -8.21 | -13.16 | |||||
| P/S TTM | 17.85 | 76.77 | - | - | - | - | - | - | - | - | - | - | |||||
| Market Cap | 685.97M | 759.45M | 1.09B | 271.68M | 175.76M | 477.22M | 574.73M | 230.05M | 235.25M | 202.86M | 205.16M | 183.54M | |||||
| Enterprise Value | 683.98M | 757.54M | 1.08B | 269.29M | 173.85M | 472.96M | 592.33M | 228.53M | 233.13M | 201.03M | 198.05M | 152.90M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -68.73M | -94.78M | -116.16M | -105.32M | -118.90M | -143.01M | -148.97M | -154.91M | -155.53M | -142.08M | 74.30M | 83.85M | |||||
| Net Debt | -1.99M | -1.91M | -9.66M | -2.40M | -1.90M | -4.26M | 17.60M | -1.52M | -2.12M | -1.83M | -7.11M | -30.64M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
OMEROS CORP (OMER) — SEC Financial Statements & Analysis
OMEROS CORP (OMER) is a pharmaceutical preparations company, incorporated in WA. OMEROS CORP trades on Nasdaq as: OMER. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), OMEROS CORP reported a Debt-to-Equity ratio of -1.85x, a Price-to-Sales (P/S) ratio of 17.85x (TTM), a Price-to-Book (P/B) ratio of -13.36x (TTM), at a market cap of $685.97M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- -1.85x
- P/S TTM
- 17.85x
- P/B TTM
- -13.36x
- Market Cap
- $685.97M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is OMEROS CORP in?
OMEROS CORP (OMER) operates in the Pharmaceutical Preparations industry.
What is OMER's market cap?
OMEROS CORP (OMER) has a market capitalization of $685.97M as of 2026-06-30.
What is OMER's P/E ratio?
OMEROS CORP (OMER)'s trailing twelve month P/E ratio is 5.50x as of 2026-06-30.
What exchange does OMER trade on?
OMEROS CORP (OMER) trades on the Nasdaq.
Where is OMEROS CORP incorporated?
OMEROS CORP is incorporated in WA.